1.554

3.60% 0.054

China Pharma Holdings Inc. (CPHI)

Overview News Price History Discussions Forecast Stock Split

China Pharma Holdings Inc. stock is traded at $1.554, with a volume of 435.20K. It is up +3.60% in the last 24 hours and down -0.13% over the past month. China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.

Previous Close:

$1.50

Open:

$1.5102

24h Volume:

435.20K

Relative Volume:

18.41

Market Cap:

$7.80M

Revenue:

$5.54M

Net Income/Loss:

$-4.74M

P/E Ratio:

-4.625

EPS:

-0.336

Net Cash Flow:

$-750.60K

1W Performance:

-8.59%

1M Performance:

-0.13%

6M Performance:

-2.26%

1Y Performance:

-16.23%

1-Day Range:

$1.41

$1.88

1-Week Range:

$1.41

$1.88

52-Week Range:

$1.20

$3.35

China Pharma Holdings Inc. Stock (CPHI) Company Profile

Name

China Pharma Holdings Inc.

Sector

Healthcare (1123)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

86 898 6681 1730

Address

No. 17, Jinpan Road, Second Floor, Haikou

Employee

276

Twitter

Next Earnings Date

Latest SEC Filings

CPHI's Discussions on Twitter

Compare CPHI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CPHI China Pharma Holdings Inc.	1.554	7.53M	5.54M	-4.74M	-750.60K	-0.336
ZTS Zoetis Inc	118.66	51.85B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	14.33	45.46B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.52	42.70B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	29.79	34.62B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	493.99	21.03B	3.08B	1.24B	1.07B	25.61

China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-08-10	Initiated	Rodman & Renshaw	Mkt Outperform

China Pharma Holdings Inc. Stock (CPHI) Latest News

Dec 12, 2025

China Pharma (NYSE:CPHI) Stock Price Down 10.2% – Should You Sell? - Defense World

Dec 12, 2025

Dec 10, 2025

China Pharma Holdings Acquires Patent in Stock Deal - TipRanks

Dec 10, 2025

Dec 08, 2025